UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mitigating the Effects of Nonadherence in Clinical Trials

Journal of clinical pharmacology, 2016-09, Vol.56 (9), p.1151-1164

2016

Volltextzugriff (PDF)

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition

Journal of clinical psychopharmacology, 2004-02, Vol.24 (1), p.62-69

2004

Volltextzugriff (PDF)

Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment

International clinical psychopharmacology, 2012-05, Vol.27 (3), p.142-150

2012

Volltextzugriff (PDF)

Failure rate and "professional subjects" in clinical trials of major depressive disorder

The journal of clinical psychiatry, 2011-09, Vol.72 (9), p.1284; author reply 1284

2011

Volltextzugriff (PDF)

Atomoxetine Augmentation of Cholinesterase Inhibitor Therapy in Patients With Alzheimer Disease: 6-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel-Trial Study

The American journal of geriatric psychiatry, 2009-09, Vol.17 (9), p.752-759

2009

Volltextzugriff (PDF)

Do Professional Subjects Retire?

The American journal of geriatric psychiatry, 2015-03, Vol.23 (3), p.S167-S167

2015

Volltextzugriff (PDF)

Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: A randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder

Clinical therapeutics, 2010-03, Vol.32 (3), p.472-491

2010

Volltextzugriff (PDF)

CNS sites cooperate to detect duplicate subjects with a clinical trial subject registry

Innovations in clinical neuroscience, 2013-02, Vol.10 (2), p.17-21

2013

Volltextzugriff (PDF)

Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial

JAMA neurology, 2015-11, Vol.72 (11), p.1324

2015

Volltextzugriff (PDF)

An Open-label, Intermediate-sized, Expanded Access Protocol of Rimegepant in the Acute Treatment of Migraine (P2-2.006)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Extreme creatine phosphokinase elevation in a 20-year-old man participating in a clinical trial of major depressive disorder

The journal of clinical psychiatry, 2008-11, Vol.69 (11), p.1832

2008

Volltextzugriff (PDF)

Cholinergic Rebound and Rapid Onset Psychosis Following Abrupt Clozapine Withdrawal

Schizophrenia bulletin, 1996, Vol.22 (4), p.591-595

1996

Volltextzugriff (PDF)

Pharmacokinetics and Tolerability of Buspirone during Oral Administration to Children and Adolescents with Anxiety Disorder and Normal Healthy Adults

Journal of clinical pharmacology, 2001-12, Vol.41 (12), p.1351-1358

2001

Volltextzugriff (PDF)

The Patient in Your Alzheimer’s Disease Study May be in Another: Duplication and Deception in Clinical Trials of Alzheimer’s Disease

The Journal of Prevention of Alzheimer's Disease, 2020, Vol.7 (1), p.43-46

2020

Volltextzugriff (PDF)

Brasofensine treatment for Parkinson's disease in combination with levodopa/carbidopa

The Annals of pharmacotherapy, 2002-02, Vol.36 (2), p.225-230

2002

Volltextzugriff (PDF)

An 8-Week Multicenter, Parallel-Group, Double-Blind, Placebo-Controlled Study of Sertraline in Elderly Outpatients With Major Depression

The American journal of psychiatry, 2003-07, Vol.160 (7), p.1277-1285

2003

Volltextzugriff (PDF)

Effects of Oral Ziprasidone and Oral Haloperidol on QTc Interval in Patients with Schizophrenia or Schizoaffective Disorder

Pharmacotherapy, 2010-02, Vol.30 (2), p.127-135

2010

Volltextzugriff (PDF)

A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder

Innovations in clinical neuroscience, 2014-01, Vol.11 (1-2), p.10-22

2014

Volltextzugriff (PDF)

Placebo-controlled study of gabapentin treatment of panic disorder

Journal of clinical psychopharmacology, 2000-08, Vol.20 (4), p.467-471

2000

Volltextzugriff (PDF)

Extreme Creatine Phosphokinase Elevation in a 20-Year-Old Man Participating in a Clinical Trail of Major Depressive Disorder

The journal of clinical psychiatry, 2008-11, Vol.69 (11), p.1832-1833

2008

Volltextzugriff (PDF)

VOLUMETRIC MRI RESULTS OF BMS AVAGACESTAT IN A PRODROMAL AD POPULATION

Alzheimer's & dementia, 2014-07, Vol.10 (4), p.P60-P61

2014

Volltextzugriff (PDF)

IC‐P‐108: VOLUMETRIC MRI RESULTS OF BMS AVAGACESTAT IN A PRODROMAL AD POPULATION

Alzheimer's & dementia, 2014-07, Vol.10 (4S_Part_6), p.P60-P61

2014

Volltextzugriff (PDF)

P2‐202: VOLUMETRIC MRI RESULTS OF BMS AVAGACESTAT IN A PRODROMAL AD POPULATION

Alzheimer's & dementia, 2014-07, Vol.10 (4S_Part_14), p.P546-P547

2014

Volltextzugriff (PDF)

VOLUMETRIC MRI RESULTS OF BMS AVAGACESTAT IN A PRODROMAL AD POPULATION

Alzheimer's & dementia, 2014-07, Vol.10 (4), p.P546-P547

2014

Volltextzugriff (PDF)

Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease

Archives of neurology (Chicago), 2012-11, Vol.69 (11), p.1430

2012

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

Humans
(24)
Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Male
(20)
Female
(19)
Middle Aged
(16)
Pharmacology & Pharmacy
(14)
Aged
(12)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Pharmacology. Drug Treatments
(11)
Adult
(10)
Aged, 80 And Over
(9)
Psychiatry
(9)
Psychology. Psychoanalysis. Psychiatry
(9)
Neuropharmacology
(8)
Alzheimer Disease - Drug Therapy
(7)
Psychopharmacology
(7)
Adolescent
(6)
Dose-Response Relationship, Drug
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mitigating the Effects of Nonadherence in Clinical Trials

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition

Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment

Failure rate and "professional subjects" in clinical trials of major depressive disorder

Atomoxetine Augmentation of Cholinesterase Inhibitor Therapy in Patients With Alzheimer Disease: 6-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel-Trial Study

Do Professional Subjects Retire?

Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: A randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder

CNS sites cooperate to detect duplicate subjects with a clinical trial subject registry

Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial

An Open-label, Intermediate-sized, Expanded Access Protocol of Rimegepant in the Acute Treatment of Migraine (P2-2.006)

Extreme creatine phosphokinase elevation in a 20-year-old man participating in a clinical trial of major depressive disorder

Cholinergic Rebound and Rapid Onset Psychosis Following Abrupt Clozapine Withdrawal

Pharmacokinetics and Tolerability of Buspirone during Oral Administration to Children and Adolescents with Anxiety Disorder and Normal Healthy Adults

The Patient in Your Alzheimer’s Disease Study May be in Another: Duplication and Deception in Clinical Trials of Alzheimer’s Disease

Brasofensine treatment for Parkinson's disease in combination with levodopa/carbidopa

An 8-Week Multicenter, Parallel-Group, Double-Blind, Placebo-Controlled Study of Sertraline in Elderly Outpatients With Major Depression

Effects of Oral Ziprasidone and Oral Haloperidol on QTc Interval in Patients with Schizophrenia or Schizoaffective Disorder

A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder

Placebo-controlled study of gabapentin treatment of panic disorder

Extreme Creatine Phosphokinase Elevation in a 20-Year-Old Man Participating in a Clinical Trail of Major Depressive Disorder

VOLUMETRIC MRI RESULTS OF BMS AVAGACESTAT IN A PRODROMAL AD POPULATION

IC‐P‐108: VOLUMETRIC MRI RESULTS OF BMS AVAGACESTAT IN A PRODROMAL AD POPULATION

P2‐202: VOLUMETRIC MRI RESULTS OF BMS AVAGACESTAT IN A PRODROMAL AD POPULATION

VOLUMETRIC MRI RESULTS OF BMS AVAGACESTAT IN A PRODROMAL AD POPULATION

Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease

Suchergebnisse filtern